The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 4, 1996, Pages 470-476

  Hamamoto, T ^a   Kisiel, W ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

factor VIIa tissue factor; heparin; Tissue factor pathway inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; HEPARIN; THROMBOPLASTIN;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CANCER CELL CULTURE; CONTROLLED STUDY; HEPARINIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION;

EID: 0029742489     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199606000-00007     Document Type: Article

References (30)

1. Rapaport SI. Inhibition of factor VIIa/tissue factor induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood 1989; 73: 359-365.
2. Broze GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-7546.
3. Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ. Cloning and characterization of a cDNA coding for lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-6004.
4. Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SD, Bajaj SP. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor evidence that endothelium is the principal site of synthesis. Proc Natl Acad Sci USA 1990; 87: 8869-8873.
5. Novotny WF, Palmier M, Wun TC, Broze GJ, Miletich JP. Purification and properties of heparin releasable lipoprotein associated coagulation inhibitor. Blood 1991; 78: 394-400.
6. Broze GJ, Warren LA, Novotny WF, et al. The lipoprotein-associated coagulation inhibitor that inhibits the factor VIIa-tissue factor complex also inhibits factor Xa: insights into its possible mechanism of action. Blood 1988; 71: 335-343.
7. Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor evidence for a two-step model of inhibition. Thromb Haemostas 1988; 60: 453-456.
8. Girard TJ, Warren LA, Novotny WF, et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989; 338: 518-520.
9. Pedersen AH, Nordfang O, Norris F, et al. Recombinant human extrinsic pathway inhibitor production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. J Biol Chem 1990; 265: 16786-16793.
10. Callander NS, Rao LVM, Nordfang O, et al. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces: evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. J Biol Chem 1992; 267: 876-882.
11. Wesselschmidt R, Likert KM, Macphail L, Broze GJ. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coag Fibrinol 1993; 4: 661-669.
12. Enjyoji K, Miyata T, Kamikubo Y, Kato H. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor. A segment, Gly212-Phe243, of the third Kunitz domain is a heparin binding site. Biochemistry 1995; 34: 5725-5735.
13. Nordfang O, Bjørn SE, Valentin S, et al. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry 1991; 30: 10371-10376.
14. Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic pathway inhibitor. Thromb Res 1988; 50: 803-813.
15. Lindahl AK, Abildgaard U, Stokke G. Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients. Thromb Res 1990; 59: 651-656.
16. Huang ZF, Wun TC, Broze GJ. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem 1993; 268: 26950-26955.
17. Jesty J, Wun TC, Lorenz A. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. Biochemistry 1994; 33: 12686-12694.
18. Petersen JGL, Meyn G, Rasmussen JS, et al. Characterization of human tissue factor pathway inhibitor (TFPI) variants expressed in Saccharomyces cerevisiae. J Biol Chem 1993; 268: 13344-13351.
19. Kondo S, Kisiel W. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism than extrinsic pathway inhibitor. Blood 1987; 70: 1947-1954.
20. Hamamoto T, Yamamoto M, Nordfang O, et al. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). J Biol Chem 1993; 268: 8704-8710.
21. Mahoney WC, Kurachi K, Hermodson MA. Formation and dissociation of the covalent complexes between trypsin and two homologous inhibitors, alpha 1-antitrypsin and antithrombin III. Eur J Biochem 1980; 105: 545-552.
22. Paborsky LR, Tate KM, Harris RJ, et al. Purification of recombinant human tissue factor. Biochemistry 1989; 28: 8072-8077.
23. Sakai T, Lund-Hansen T, Paborsky L, Pedersen AH, Kisiel W. Binding of human factor VII and VIIa to a human bladder carcinoma cell line (J82). J Biol Chem 1989; 264: 9980-9988.
24. Engvall E. Enzyme immunoassay ELISA and EMIT. Meth Enzymol 1980; 70: 419-439.
25. 152→Glu site directed mutant of recombinant human blood clotting factor VII. Biochemistry 1990; 29: 3413-3420.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 1976; 72: 248-254.
27. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30: 10819-10824.
28. Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry 1986; 25: 4007-4020.
29. Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factor IX and X by recombinant human factor VIIa: effect of calcium, phospholipids, and tissue factor. Biochemistry 1990; 29: 9418-9425.
30. Bourin MC, Lindahl U. Glycosaminoglycans and regulation of blood coagulation. Biochem J 1993; 289: 313-330.